ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,020 | -38.8% | 1,201 | -8.2% | 0.00% | -100.0% |
| Q4 2022 | $14,741 | +17.8% | 1,308 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $12,518 | -40.4% | 1,308 | +5.3% | 0.00% | 0.0% |
| Q1 2022 | $20,990 | -81.2% | 1,242 | -76.1% | 0.00% | -50.0% |
| Q4 2021 | $111,898 | -70.9% | 5,207 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $384,589 | +5.3% | 5,207 | +5.1% | 0.01% | +20.0% |
| Q1 2021 | $365,308 | +41.2% | 4,954 | +65.1% | 0.01% | +25.0% |
| Q4 2020 | $258,686 | +128.4% | 3,001 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $113,258 | – | 3,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $43,843,661 | 24.30% |
| Vivo Capital, LLC | 4,220,048 | $19,074,617 | 1.32% |
| Logos Global Management LP | 1,500,000 | $6,780,000 | 0.97% |
| Orbimed Advisors | 2,871,000 | $12,976,920 | 0.26% |
| Samsara BioCapital, LLC | 262,786 | $1,187,793 | 0.24% |
| BRAIDWELL LP | 1,249,900 | $5,649,548 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,767 | 0.18% |
| Artal Group S.A. | 500,000 | $2,260 | 0.13% |
| Nan Fung Group Holdings Ltd | 41,950 | $189,614 | 0.13% |
| Redmile Group, LLC | 586,977 | $2,653,136 | 0.12% |